BE905796A - HUMAN MANGANESE SUPEROXIDE DISMUTASE DNA, ITS EXPRESSION IN BACTERIA, AND HUMAN MANGANESE SUPEROXIDE DISMUTASE RECOVERY METHOD. - Google Patents

HUMAN MANGANESE SUPEROXIDE DISMUTASE DNA, ITS EXPRESSION IN BACTERIA, AND HUMAN MANGANESE SUPEROXIDE DISMUTASE RECOVERY METHOD.

Info

Publication number
BE905796A
BE905796A BE0/217445A BE217445A BE905796A BE 905796 A BE905796 A BE 905796A BE 0/217445 A BE0/217445 A BE 0/217445A BE 217445 A BE217445 A BE 217445A BE 905796 A BE905796 A BE 905796A
Authority
BE
Belgium
Prior art keywords
superoxide dismutase
manganese superoxide
human manganese
bacteria
expression
Prior art date
Application number
BE0/217445A
Other languages
French (fr)
Original Assignee
Bio Technology General Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bio Technology General Corp filed Critical Bio Technology General Corp
Publication of BE905796A publication Critical patent/BE905796A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004Oxidoreductases (1.)
    • C12N9/0089Oxidoreductases (1.) acting on superoxide as acceptor (1.15)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43Enzymes; Proenzymes; Derivatives thereof
    • A61K38/44Oxidoreductases (1)
    • A61K38/446Superoxide dismutase (1.15)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

Molécule d'ADN à double brin qui comprend de l'ADN encodant de la superoxyde dismutase de manganèse humaine, ces molécules pouvant etre introduites dans des cellules procaryotiques, par exemple bactériennes, ou eucaryotiques, par exemple des levures ou des cellules de mammifères, les cellules résultantes étant cultivées sous des conditions appropriées de manière à produire de la superoxyde dismutase de manganèse humaine ou des analogues de celle-ci qui peuvent ensuite etre récupérés.Double-stranded DNA molecule which comprises DNA encoding human manganese superoxide dismutase, these molecules being able to be introduced into prokaryotic cells, for example bacterial, or eukaryotic cells, for example yeasts or mammalian cells, resulting cells being cultured under suitable conditions to produce human manganese superoxide dismutase or analogs thereof which can then be recovered.

BE0/217445A 1985-11-22 1986-11-20 HUMAN MANGANESE SUPEROXIDE DISMUTASE DNA, ITS EXPRESSION IN BACTERIA, AND HUMAN MANGANESE SUPEROXIDE DISMUTASE RECOVERY METHOD. BE905796A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US80109085A 1985-11-22 1985-11-22
US90705186A 1986-09-12 1986-09-12

Publications (1)

Publication Number Publication Date
BE905796A true BE905796A (en) 1987-03-16

Family

ID=27122291

Family Applications (1)

Application Number Title Priority Date Filing Date
BE0/217445A BE905796A (en) 1985-11-22 1986-11-20 HUMAN MANGANESE SUPEROXIDE DISMUTASE DNA, ITS EXPRESSION IN BACTERIA, AND HUMAN MANGANESE SUPEROXIDE DISMUTASE RECOVERY METHOD.

Country Status (21)

Country Link
JP (2) JP2609449B2 (en)
AT (1) AT400443B (en)
AU (1) AU607897B2 (en)
BE (1) BE905796A (en)
CA (1) CA1341362C (en)
CH (1) CH676990A5 (en)
DE (1) DE3639725C2 (en)
DK (1) DK534686A (en)
ES (1) ES2003518A6 (en)
FI (1) FI90353C (en)
FR (1) FR2590591B1 (en)
GB (1) GB2183658B (en)
GR (1) GR862713B (en)
HK (1) HK75195A (en)
IE (1) IE59498B1 (en)
IL (2) IL106449A (en)
IT (1) IT1205418B (en)
LU (1) LU86676A1 (en)
NL (1) NL8602960A (en)
PT (1) PT83792B (en)
SE (1) SE8604884L (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0284105B1 (en) * 1987-03-27 1995-11-15 Bio-Technology General Corporation Human manganese superoxide dismutase and methods of treatment
EP0282899B1 (en) * 1987-03-14 1996-01-10 BOEHRINGER INGELHEIM INTERNATIONAL GmbH Human manganese superoxide dismutase (hMn-SoD)
US5540911A (en) * 1985-11-22 1996-07-30 Bio-Technology General Corp. Methods of use of human manganese superoxide dismutase

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS62215532A (en) * 1986-03-18 1987-09-22 Ube Ind Ltd Anti-inflammatory drug
JPH0643341B2 (en) * 1986-03-27 1994-06-08 宇部興産株式会社 Organ function improving agent
JPH0643340B2 (en) * 1986-09-03 1994-06-08 宇部興産株式会社 Ischemic heart disease drug
JPS6377822A (en) * 1986-09-18 1988-04-08 Ube Ind Ltd Organ function improver
US6326003B1 (en) 1986-10-14 2001-12-04 Chiron Corporation Manganese superoxide dismutase cloning and expression in microorganisms
US5260204A (en) * 1987-03-14 1993-11-09 Boehringer Ingelheim International Gmbh Human manganese superoxide dismutase (hMn-SOD)
JPH01233228A (en) * 1988-03-11 1989-09-19 Toyo Jozo Co Ltd Metastasis preventive of malignant tumor cells
US5772996A (en) * 1990-08-03 1998-06-30 Public Health Laboratory Service Board Pharmaceutical compositions containing superoxide dismutase from Bacillus Stearothermophilus and Bacillus Caldotenax
DE4038563A1 (en) * 1990-12-04 1992-06-11 Gruenenthal Gmbh USE OF SUPEROXIDE DISMUTASES FOR PROPHYLAXIS AND / OR TREATMENT OF ORGAN FAILURE IN RISK PATIENTS WITH POLYTRAUMA
ATE209928T1 (en) * 1992-09-09 2001-12-15 Bio Technology General Corp USE OF MANGANEOUS SUPEROXIDE DISMUTASE (MN-SOD) FOR THE PRODUCTION OF MEDICINAL PRODUCTS FOR THE TREATMENT OF DISEASES IN LOW DOSES
DE4239877C1 (en) * 1992-11-27 1994-03-17 Boehringer Ingelheim Int Stabilized superoxide dismutase (SOD) composition

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS56102787A (en) * 1980-01-18 1981-08-17 Mamoru Sugiura Preparation of human placenta superoxide dismutase
BG49718A3 (en) * 1983-07-15 1992-01-15 Bio- Technology General Corp Method for preparing of polypeptid with superoxiddismutasne activitty
EP0138111B1 (en) * 1983-10-03 1991-11-21 Chiron Corporation Superoxide dismutase cloning and expression in microorganisms

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5540911A (en) * 1985-11-22 1996-07-30 Bio-Technology General Corp. Methods of use of human manganese superoxide dismutase
US6361772B1 (en) 1985-11-22 2002-03-26 Bio-Technology General Corp. Human manganese superoxide dismutase DNA, its expression and method of recovering human manganese superoxide dismutase
US6610520B1 (en) 1985-11-22 2003-08-26 Bio-Technology General Corp. Gene encoding human manganese superoxide dismutase and recombinant polypeptide encoded thereby
EP0282899B1 (en) * 1987-03-14 1996-01-10 BOEHRINGER INGELHEIM INTERNATIONAL GmbH Human manganese superoxide dismutase (hMn-SoD)
EP0284105B1 (en) * 1987-03-27 1995-11-15 Bio-Technology General Corporation Human manganese superoxide dismutase and methods of treatment

Also Published As

Publication number Publication date
FI90353B (en) 1993-10-15
FI864756A (en) 1987-05-23
GB8627294D0 (en) 1986-12-17
IT1205418B (en) 1989-03-15
IT8667865A0 (en) 1986-11-21
FI90353C (en) 1994-01-25
IL80702A0 (en) 1987-02-27
IE862851L (en) 1987-05-22
DE3639725A1 (en) 1987-07-23
IL106449A (en) 1997-02-18
DK534686A (en) 1987-05-23
JP2967557B2 (en) 1999-10-25
HK75195A (en) 1995-05-26
FI864756A0 (en) 1986-11-21
NL8602960A (en) 1987-06-16
JP2609449B2 (en) 1997-05-14
GR862713B (en) 1987-03-24
AT400443B (en) 1995-12-27
AU607897B2 (en) 1991-03-21
IE59498B1 (en) 1994-03-09
ES2003518A6 (en) 1988-11-01
JPS62289187A (en) 1987-12-16
GB2183658B (en) 1990-04-25
CA1341362C (en) 2002-05-28
ATA308986A (en) 1995-05-15
LU86676A1 (en) 1987-05-04
FR2590591B1 (en) 1989-12-01
JPH08289792A (en) 1996-11-05
SE8604884D0 (en) 1986-11-14
DE3639725C2 (en) 1998-02-19
GB2183658A (en) 1987-06-10
IL106449A0 (en) 1993-11-15
SE8604884L (en) 1987-05-23
CH676990A5 (en) 1991-03-28
PT83792B (en) 1989-01-17
PT83792A (en) 1986-12-01
FR2590591A1 (en) 1987-05-29
DK534686D0 (en) 1986-11-07
AU6497586A (en) 1987-05-28

Similar Documents

Publication Publication Date Title
BE905796A (en) HUMAN MANGANESE SUPEROXIDE DISMUTASE DNA, ITS EXPRESSION IN BACTERIA, AND HUMAN MANGANESE SUPEROXIDE DISMUTASE RECOVERY METHOD.
Dudai et al. Purification by affinity chromatography of acetylcholinesterase from electric organ tissue of electric eel subsequent to tryptic treatment
FR2466503B1 (en) METHOD FOR CULTIVATION OF ANIMAL CELLS IN THE FORM OF SUSPENSION AND SINGLE-LAYER CULTURES IN FERMENTATION CONTAINERS
DK170186A (en) BIOLOGICALLY CULTURAL CULTURE OF A TREASURE LACTOBACILLUS ACIDOPHILUS AND PROCEDURE FOR INSULATING SUCH CULTURE AND APPLICATION OF THIS SUBSTANCE MEDICINE
YU61799A (en) Procedure for the fermentativen production of d-pantothenic acid by means of strenthening pan d-genes in microorganisms
DE3777536D1 (en) CONTAINER, INTENDED TO RECEIVE ONE OR MORE MICRO-ORGANISM CULTURE MEDIA.
FR2373289A1 (en) METHOD FOR THE PREPARATION OF A MASS OF CHARGED CELLS IN SUSPENSION IN A PHYSIOLOGICAL SOLUTION
GR3005297T3 (en)
GB1384179A (en) Treatment of microorganism cells
KR870004130A (en) Cultivation method of recombinant bacterial cells
Capaldi et al. Isolation of a major hydrophobic protein of the mitochondrial inner membrane
DE3477401D1 (en) Immobilization of catalytically active microorganisms in agar gel fibers
Qureshi et al. The isolation of acyl carrier protein from the pigeon liver fatty acid synthetase complex II
KR910020171A (en) Method for producing L-(-)-carnitine by biocatalyst from crotonovebetaine and protein strain used in the method
BR9400600A (en) Processes for the production of a recombinant protein and / or glycosylphosphatidylinositol (GPI) in cells of eukaryotic microorganisms and to obtain S. cerevisae yeasts; yeast cell nucleotide sequence; culture medium; medicine or vaccine; and product of said processes
FR2586699B1 (en) MILK FRACTIONS, PROCESS FOR OBTAINING SUCH FRACTIONS AND CELL CULTURE MEDIA CONTAINING THESE FRACTIONS
FR2354314A1 (en) NEW ANTIBIOTICS CALLED NEOVIRIDOGRISEINS AND THEIR PREPARATION PROCESS
JPS57122792A (en) Preparation of cholesterol oxidase
RU97122342A (en) BIOFERTILIZER METHOD
JPS56147706A (en) Humectant for skin
FR2603040B1 (en) PROTEIN, DNA SEQUENCE, POXVIRUSES, CELLS AND THEIR CULTURE PROCESS, AS WELL AS THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, USEFUL IN THE PREVENTION OF SCHISTOSOMOSIS
EP0218472A3 (en) Process for production of superoxide dismutase
DE69316352D1 (en) A METHOD FOR RESTRICTING THE SURVIVAL OF GENETICALLY PRODUCED MICROORGANISMS IN THEIR SURROUNDINGS
Kanemoto et al. Nitrogen fixation in Rhodospirillum rubrum: The regulation of Fe protein and its activating enzyme.
DE3062880D1 (en) Apoglucose oxidase preparation and its production

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: *BIO-TECHNOLOGY GENERAL CORP.

Effective date: 20021130